Molecular and transcriptional responses to sarin exposure

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 665-682

  Damodaran, T V ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349262211     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374484-5.00044-4     Document Type: Chapter

References (106)

1. Abdel-Rahman A., Shetty A.K., Abou-Donia M.B. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neuroscience 2002, 113:721-741.
2. Abou-Donia M.B. Organophosphorus ester-induced delayed neurotixicity. Annu. Rev. Pharmacol. Toxicol. 1990, 21:511-548.
3. Abou-Donia M.B. Involvement of cytoskeletal proteins in the mechanisms of organophosphorus ester-induced delayed neurotoxicity. Clin. Exp. Pharmacol. Physiol. 1995, 25:358-359.
4. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch. Environ. Health 2003, 58:484-487.
5. Abou-Donia M.B., Dechkovskaia A.M., Goldstein L.B., Bullman S.L., Khan W.A. Sensorimotor deficit and cholinergic changes following co-exposure with pyridostigmine bromide (PB) and sarin in rats. Toxicol. Sci. 2002, 66:148-158.
6. Abu-Qare A.W., Abou-Donia M.B. Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrotyrosinee and 8-hydroxy-20-deoxyguanosine, biomarkers of oxidative stress. Toxicol. Lett. 2001, 123:51-58.
7. Abu-Qare A.W., Suliman H.B., Abou-Donia M.B. Induction of urinary excretion of 3-nitrotyrosine, a marker of oxidative stress, following administration of pyridostigmine bromide, DEET (N, N-diethyl-m-toluamide) and permethrin, alone and in combination in rats. Toxicol. Lett. 2001, 121:127-134.
8. Araki T., Kasai K., Yamasue H., Kato N., Kudo N., Ohanti T., Nakagome K., Kirihara K., Yamada H., Abe O., Iwanami A. Association between lower P300 amplitude and smaller anterior cingulate cortex volume in patients with posttraumatic stress disorder: a study of victims of Tokyo subway sarin attack. Neuroimage 2005, 25:43-50.
9. Armstrong D.M. Ultrastructural characterization of choline acetyltransferase-containing neurons in the basal forebrain of rat: evidence for a cholinergic innervation of intracerebral vessels. J. Comp. Neurol. 1986, 250:81-92.
10. Black K.L. Biochemical opening of the blood-brain barrier. Adv. Drug Deliv. Rev. 1995, 15:37-52.
11. Bloch-Shilderman E., Kadar T., Levy A., Sahar R., Rabinovitz I., Gilat E. Subcellular alterations of protein kinase C isozymes in the rat brain after organophosphate poisoning. J. Pharmacol. Exp. Ther. 2005, 313:1082-1089.
12. Boschert U., Merlo-Pich E., Higgins G., Roses A.D., Catsicas S. Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiol. Dis 1999, 6:508-514.
13. Bryk B., BenMoyal-Segal L., Podoly E., Livnah O., Eisenkraft A., Luria S., Cohen A., Yehezkelli Y., Hourvitz A., Soreq H. Inherited and acquired interactions between AChE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. J. Neurochem. 2005, 92:1216-1227.
14. Burchfiel J.L., Duffy F.H. Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav. Toxicol. Teratol. 1982, 4:767-778.
15. Burchfiel J.L., Duffy F.H., Van Sim M. Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicol. Appl. Pharmacol. 1976, 35:365-379.
16. Cameron H.A., Hazel T.G., McKay R.D. Regulation of neurogenesis by growth factors and neurotransmitters. J. Neurobiol. 1998, 36:287-306.
17. Chapman S., Kadar T., Gilat E. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. Neurotoxicology 2006, 27:277-283.
18. Choi R.C., Yung L.Y., Dong T.T., Wan D.C., Wong Y.H., Tsim K.W. The calcitonin gene-related peptide-induced acetylcholinesterase synthesis in cultured chick myotubes is mediated by cyclic AMP. J. Neurochem. 1998, 71:152-160.
19. Costa L.G. Muscarinic receptors and the developing nervous system. Receptors in the Developing Nervous System 1993, 21-42. Chapman & Hall, London. I.S. Zagon, P.J. McLaughlin (Eds.).
20. Costa L.G. Signal transduction in environmental neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 1998, 38:21-43.
21. Curtis B.F., Tetz L.M., Compton J.R., Doctor B.P., Gordon R.K., Nambiar M.P. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure. J. Cell. Biochem. 2005, 96:839-849.
22. Curtin B.F., Seetharam K.I., Dhoieam P., Gordon R.K., Doctor B.P., Nambiar M.P. Reveratrol induces catalytic bioscavenger parapxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines. J. Cell. Biochem. 2008, 103:1524-1535.
23. Damodaran T.V., Abou-Donia M.B. Alterations in levels of mRNAs coding for glial fibrillary acidic protein (GFAP) and vimentin genes in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP). Neurochem. Res. 2000, 25:809-816.
24. Damodaran, T.V., Mecklai, A.A., Abou-Donia, M.B. (2002a). Sarin causes altered time course of mRNA expression of alpha tubulin in the central nervous system of rats. Neurochem. Res.27: 177-81.
25. Damodaran, T.V., Bilska, M.A., Rahman A.A., Abou-Donia, M.B. (2002b). Sarin causes early differential alteration and persistent overexpression in mRNAs coding for glial fibrillary acidic protein (GFAP) and vimentin genes in the central nervous system of rats. Neurochem. Res.27: 407-15.
26. Damodaran, T.V., Abdel-Rahman, A.A., Suliman, H.B., Abou-Donia, M.B. (2002c). Early differential elevation and persistence of phosphorylated cAMP-response element binding protein (p-CREB) in the central nervous system of hens treated with diisopropyl phosphorofluoridate, an OPIDN-causing compound. Neurochem. Res.27: 183-93.
27. Damodaran T.V., Jones K.H., Patel A.G., Abou-Donia M.B. Sarin (nerve agent GB)-induced differential expression of mRNA coding for the acetylcholinesterase gene in rat central nervous system. Biochem. Pharmacol. 2003, 65:2041-2047.
28. Damodaran, T.V., Patel, A.G., Greenfield, S.T., Dressman, H.K., Lin, S.M., Abou-Donia, M.B. (2006a). Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure. Biochem. Pharmacol.71: 497-520.
29. Damodaran, T.V., Greenfled, S.T., Patel, A.G., Dressman, H.K., Lin, S.A., Abou-Donia, M.B. (2006b). Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure. Neurochem. Res.31: 361-81.
30. Das G.P., Shaik P., Jamil K. Cyotoxicity and genotoxicity induced by the pesticide profenofos on cultured human peripheral blood lymphocytes. Drug Chem. Toxicol 2006, 29:313-322.
31. Dave J.R., Conners R.A., Genoverse R.F., Whippie R.A., Chen R.W., Deford S.M., Moran A.V., Tortella E.C. DNA fragmentation in leukocytes following repeated low dose sarin exposure in guinea pigs. Cell. Mol. Life Sci. 2007, 64:2823-2828.
32. Davies O.R., Holland P.R. Effect of oximes and atropine upon the development of delayed neurotoxic signs in chickens following poisoning with DFP and sarin. Biochem. Pharmacol. 1972, 21:3145-3151.
33. Dworkin M.B., David I.B. Use of a cloned library for the study of abundant poly (A)+ RNA during Xenopus laevis development. Dev. Biol. 1980, 76:449-464.
34. Foster T.C. Interaction of rapid signal transduction cascades and gene expression in mediating estrogen effects on memory over the life span. Front. Neuroendocrinol. 2005, 26:51-64.
35. Golomb B.A. Acetlycholinesterase inhibitors and Gulf War illness. Proc. Natl Acad. Sci. USA 2008, 105:4295-4300.
36. Grauer E., Chapman S., Rabinovitz I., Raveh L., Weissman B.A., Kadar T., Alison N. Single whole body exposure to sarin vapor in rats: long term neuronal and behavioral deficits. Toxicol. Appl. Pharmacol. 2008, 227:265-274.
37. Gupta R.C., Milatovic D., Dettbarn W.D. Depletion of energy metabolite following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants. Neurotoxicology 2001, 22:271-282.
38. 2+/calmodulin-dependent protein kinase II in tau phosphorylation. Arch. Biochem. Biophys. 1999, 365:268-278.
39. Gupta R.P., Abdel-Rahman A.A., Wilmarth K.W., Abou-Donia M.B. Alterations in neurofilament axonal transport in the sciatic nerve of diisopropyl phosphorofluridate (DFP)-treated hen. Biochem. Pharmacol. 1997, 53:1799-1806.
40. 2+/calmodulin-dependent protein kinase II alpha subunit and its mRNA expression in diisopropyl phosphorofluoridate (DFP)-treated hen central nervous system. Mol. Cell. Biochem. 1998, 181:29-39.
41. Gupta R.P., Lin W.W., Abou-Donia M.B. Enhanced mRNA expression of neurofilament subunits in the brain and spinal cord of diisopropyl phosphorofluoridate-treated hens. Biochem. Pharmacol. 1999, 57:1245-1251.
42. Gupta, R.P., Damodaran, T.V., Abou-Donia, M.B. (2000a). C-fos mRNA induction in the central and peripheral nervous systems of diisopropyl phosphorofluoridate (DFP)-treated hens. Neurochem. Res.25: 327-34.
43. Gupta, R.P., Abdel-Rahman, A., Jensen, K.F., Abou-Donia, M.B. (2000b). Altered expression of neurofilament subunits in diisopropyl phosphorofluoridate-treated hen spinal cord and their presence in axonal aggregations. Brain Res.878: 32-47.
44. Heaton K.J., Palumbo C.L., Proctor S.P., Killiany R.J., Yurgelun-Todd D.A., White R.F. Quantitative magnetic resonance brain imaging in US army veterans of the 1981 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology 2007, 28:761-769.
45. Himura K., Murayama S., Nishiyama K., Shione T., Iwase H., Nagao M., et al. Distal sensory axonopathy after sarin intoxication. Neurology 1998, 51:1195-1197.
46. Hoskins B., Liu D.D., Ho I.K. Acute effects of soman, sarin, and tabun on microsomal and cytosolic components of the calmodulin system in rat striatum. J. Neurochem. 1986, 46:265-269.
47. Jariel-Encontre C.S., SteffA.M., Pariat C., Acquaviva O., Furstoss M., Piechaczyk M. Complex mechanisms for c-fos and c-jun degradation. Mol. Biol. Rep. 1997, 24:51-56.
48. Jones K.H., Dechkovskaia A.M., Herrick E.A., Abdel-Rahman A.A., Khan W.A., Abou-Donia M.B. Subchronic effects following a single sarin exposure on blood-brain and blood-testes barrier permeability, acetylcholinesterase, and acetylcholine receptors in the central nervous system of rat: a dose-response study. J. Toxicol. Environ. Health A 2000, 61:695-707.
49. Kadar T., Shapira S., Cohen G., Sahar R., Alkalay D., Raveh L. Sarin induced neuropathology in rats. Hum. Exp. Toxicol 1995, 14(3):252-259.
50. Kalra R., Singh S.P., Razani-Boroujerdi S., Langley R.J., Blackwell W.B., Henderson R.F., Sopori M.L. Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system. Toxicol. Appl. Pharmacol. 2002, 15:82-87.
51. Kassa J., Skopec F., Vachek J. The long-term changes in liver DNA and total protein contents following low level sarin exposure in rats. Acta Med. 2000, 43:19-22.
52. Kassa J., Koupilova M., Herink J., Vachek J. The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Med. (Hradec Kralove) 2001, 44:21-27.
53. Kassa J., Krocova Z., Sevelova L., Sheshka V., Kasalova I., Neubauervoa V. The influence of single or repeated low-level sarin exposure on immune functions of inbred BALB/c mice. Basic. Clin. Pharmacol. Toxicol. 2004, 94:139-143.
54. Kaufer D., Friedman A., Seidman S., Soreq H. Anticholinesterase induce multigenic transcriptional feedback response suppressing cholinergic neurotransmisison. Chem. Biol. Interact. 1999, 199-20:349-360.
55. Kawashima K., Fujii T. Basic and clinical aspects of non-neuronal acetylcholine; overview of non-neuronal cholinergic systems and their biological significance. J. Pharmacol. Sci. 2008, 106:167-173.
56. Kim Y.M., Barak L.S., Caron M.G., Benovic J.L. J. Biol. Chem. 2002, 277:16837-16846.
57. 2+ by toxic agents. An index of potential neurotoxicity. Trends Pharmacol. Sci. 1988, 9:154-156.
58. Kristian T., Siesjo B.K. Calcium-related damage in ischemia. Life Sci. 1996, 59:357-367.
59. Lamour Y., Epelbaum J. Interactions between cholinergic and peptidergic systems in the cerebral cortex and hippocampus. Prog. Neurobiol. 1988, 31:109-148.
60. Landgrebe M., Laskawi R., WolffJ.R. Transient changes in cortical distribution of S100 proteins during reorganization of somatotopy in the primary motor cortex induced by facial nerve transection in adult rats. Eur. J. Neurosci. 2000, 12:3729-3740.
61. Larkin J.E., Frank B.C., Gavras H., Sultana R., Quackenbush J. Independence and reproducibility across microarray platforms. Nat. Methods 2005, 2:337-344.
62. Lehmann J., Langer S.Z. Muscarinic receptors on dopamine terminals in the cat caudate nucleus neurotransmitter of [3H] dopamine release in vitro by endogenous acetylcholine. Brain Res. 1982, 248:61-69.
63. Levy A., Chapman S., Cohen G., Raveh L., Rabinovitz I., Manistersky E., Kapon Y., Allon N., Gilat E. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: comparative efficacy of three oximes. J. Appl. Toxicol. 2004, 24:501-504.
64. Li Q., Hirata Y., Piao S., Minami M. The byproducts generated during sarin-synthesis in the Tokyo sarin disaster induced inhibition of natural killer and cytotoxic T lymphocyte activity. Toxicology 2000, 146:209-220.
65. Li B., Duysen E.G., Lockridge O. Gene transfer of acetylcholinesterase protects the knockout mouse from the toxicity of DFP. J. Mol. Neurosci. 2006, 30:79-80.
66. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971.
67. Martins R.N., Taddei K., Kendall C., Evin G., Bates K.A., Harvey A.R. Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue. Neuroscience 2001, 106:557-569.
68. Masuda N., Takatsu M., Morinari H. Sarin poisoning in Tokyo subway. Lancet 1995, 345:1446-1447.
69. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21:559-579.
70. Meshorer E., Soreq H. Virtues and woes of AchE alternative splicing in stress-related neuropathologies. Trends Neurosci. 2006, 29:216-224.
71. Mioduszewski R., Manthel J., Way R., Burnett D., Gaviola B., Muse W., Thomson S., Sommerville D., Crosier R. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol. Sci. 2002, 66:176-184.
72. Miyaki K., Nishiwaki Y., Maekawaa K., Ogawa Y., Asukai N., Yoshimura K., Etoh N., et al. Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack. J. Occup. Health 2005, 47:299-304.
73. Nicotera P., Bellomo G., Orrenius S. Calcium-mediated mechanisms in chemically-induced cell death. Annu. Rev. Pharmacol. Toxicol. 1992, 34:449-470.
74. Niijima H., Nagao M., Nakajima M., Takatori T., Iwasa M., Maeno Y., Koyama H., Isobe I. The effects of sarin-like and soman-like organophosphorus agents on MAPK and JNK in rat brains. Forensic Sci. Int. 2000, 112:171-178.
75. Oakley R.H., Laporte S.A., Holt J.A., Barak L.S., Caron M.G. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 1999, 274:32248-32257.
76. Ohkubo N., Mitsuda N., Tamatani M., Yamaguchi A., Lee Y.D., Ogihara T., Vitek M.P., Tohyama M. Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J. Biol. Chem. 2001, 276:3046-3053.
77. Pant S.C., Vijayaraghavan R., Das Gupta S. Sarin induced lung pathology and protection by standard therapy regime. Biomed. Environ. Sci. 1993, 6:103-111.
78. Pena-Philippides J.C., Razani-Boroujerdi S.R., Singh S.P., Langley R.J., Mishra N.C., Henderson R.F., Sopori M.L. Long-and short-term changes in the neuroimmune-endocrine parameters following inhalation exposures of F344 rats to low-dose sarin. Toxicol. Sci. 2007, 97:181-188.
79. Pippig S., Andexinger S., Daniel K., Puzicha M., Caron M.G., Lefkowitz R.J., Lohse M.J. Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors. J. Biol. Chem. 1993, 268:3201-3208.
80. Potti A., Ganti A.K., Tuchman S.A., Sholes K., Langness E., Koka V., Koch M. HER-2/neu and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small lung carcinoma (ESSCLC). J. Carcinog. 2005, 9:4-8.
81. Proctor S.P., Heaton K.J., Heeren T., White R.F. Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology 2006, 27:931-939.
82. Quirion R., Richard J., Dam T.V. Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex. Brain Res. 1985, 333:345-349.
83. Ray D.E. Chronic effects of low level exposure to anticholinesterase mechanistic review. Toxicol. Lett. 1998, 102-3:527-533.
84. Recio R., Robbins W.A., Borja-Aburto V., Moran-Martinez J., Froines J.R., Hernandez R.M., Cebrian M.E. Organophosphorous pesticide exposure increases the frequency of sperm sex null anuploidy. Environ. Health Perspect. 2001, 109:1237-1240.
85. Sargentg T.D. Isolation of differentially expressed genes. Methods Enzymol. 1998, 152:423-432.
86. Scatton B., Bartholini G. Modulation of cholinergic transmission in the rat brain by GABA. Brain Res. Bull. 1980, 5:222-229.
87. Scharer O.D., Jiricny J. Recent progress in the biology, chemistry, and structural biology of DNA glycosylases. Bioassays 2001, 23:270-281.
88. Sekowski J.W., Bucker J., Menking D., Valdes J.J., Midoduszrwski R., Thomson S., Whaley C. Gene expression changes following low level exposure to sarin vapor. In 23rd Army Science Conference 2002, Transformation Science and Technology for the Army, Washington, DC.
89. Sirivarasai J., Kaojarern S., Yoovathaworn K., Sura T. Paraoxonase (PON1) polymorphism and activity as the determination of sensitivity to organophosphates in human subjects. Chem. Biol. Interact. 2007, 168:184-192.
90. Smallridge R.C., Carr F.E., Fein H.G. Diisopropylfluorophosphate (DFP) reduces serum prolactin, thyrotropin, luteinizing hormone, and growth hormone and increases adrenocorticotropin and corticosterone in rats: involvement of dopaminergic and somatostatinergic as well as cholinergic pathways. Toxicol. Appl. Pharmacol. 1991, 108:284-295.
91. Smith M.I., Elvove E., Frazier W.H. The pharmacological action of certain phenol esters with special reference to the etiology of so called ginger paralysis. Public Health Rep 1930, 45:2509-2524.
92. Solberg Y., Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 1997, 18:183-185.
93. Sopori M.L., Geng Y., Savage S.M., Kozak W., Soszynski D., Kluger M.J., Perryman E.K., Snow G.E. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 1998, 23:189-204.
94. Staddon J.M., Smales C., Schulze C., Esch F.S., Rubin L.L. p120, a p120-related protein (p100), and the cadherin/catenin complex. J. Cell. Biol. 1995, 130:369-381.
95. Tracey K.J. Fat meets the cholinergic anti-inflammatory pathway. J. Exp. Med. 2005, 202:1017-1021.
96. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science 1995, 270:484-487.
97. Walton, M., Connor, B., Lawlor, P., Young, D., Sirimanne, E., Gluckman, P., Cole, G., Dragunow, M. (1999b). Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res. Rev.29: 137-68.
98. Weldon D.T., Rogers S.D., Ghilardi J.R., Finke M.P., Cleary J.P., O'Hare E., Esler W.P., Maggio J.E., Mantyh P.W. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 1998, 18:2161-2173.
99. Williams N.H., Harrison J.M., Read R.W., Black R.M. Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents. Arch. Toxicol. 2007, 811:627-639.
100. Woodin A.M., Wieneke A.A. Action of DFP the leucocyte and the axon. Nature 1970, 227:460-463.
101. Xie K., Gupta R.P., Abou-Donia M.B. Alteration in cytoskeletal protein levels in sciatic nerve and post treatment of diisopropylphosphorofluoridate (DFP) treated hen with phenylmethylsulphonyl fluoride. Neurochem. Res. 2001, 26:235-243.
102. Yamasue H., Abe O., Kasai K., Suga M., Iwanami A., Yamada H., Tochigi M. Human brain structural change related to acute single exposure to sarin. Ann. Neurol. 2007, 61:37-46.
103. Yokoyama K., Araki S., Murata K., Nishikitani M., Okumura T., Ishimatus S., et al. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to posttraumatic stress disorder. Arch. Environ. Health 1998, 53:2489-2560.
104. Young J.F., Gough B.J., Suber R.L., Gaylor D.W. Correlation of blood cholinesterase levels with the toxicity of sarin in rats. J. Toxicol. Environ. Health A 2001, 62:161-174.
105. Zabrodskii P.F., Germanchuk V.G., Mandych V.G., Kadushkin A.M. Role of Th1 and Th2 lymphocytes and cytokines produced by these cells in suppression of immune reactions during subacute poisoning with anticholinesterase toxicants. Bull. Exp. Biol. Med. 2007, 144:57-59.
106. Zhao P., Waxman S.G., Hains B.C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci. 2007, 27:2357-2368.